Wells Fargo Initiates MEI Pharma With Outperform

Analysts at Wells Fargo initiated coverage on

with a Outperform rating. MEI Pharma shares have declined 54.23% over the past 52 weeks, while the S&P 500 index has gained 14.77% in the same period. MEI Pharma's shares rose 0.77% to close at $3.95 yesterday.